We measured the level of phosphorylated tau (AT180) in hNSC- and vehicle-injected NSE/APPsw transgenic mice because aberrant phosphorylation of tau worsens cognitive function via axonal and synaptic disruption in AD [2, 6]. This evidence concerns the gene ENO2 and Alzheimer disease.